At Anveta Therapeutics, we identify and advance promising early-stage therapeutic programs emerging from academic and institutional research. We partner closely with originating scientists to translate novel biology into differentiated small-molecule medicines and progress them through discovery, IND-enabling studies, and early clinical development.

Anveta aims to accelerate the path from innovative science to meaningful clinical impact –

1. Acquire or collaborate to co-develop drug candidates
2. Develop drugs in-house and use drug development platform to maximize value
3. Drive value creation through clear development inflection points and strategic partnerships for exit

Interested in learning more about our Model?